Effect of methylprednisolone on phospholipase A2 activity and lung surfactant degradation in acute lung injury in rabbits

Kenji Kuwabara, Shingo Furue, Yasuhiko Tomita, Masahiko Ueno, Takashi Ono, Akihiro Matsukawa, Masaru Yoshinaga, Katsuya Mikawa, Kahoru Nishina, Makoto Shiga, Hidefumi Obara, Yozo Hori

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Glucocorticoids are the most potent and widely used anti-inflammatory agents, but they are not particularly effective against early phase of acute respiratory distress syndrome. We investigated whether methylprednisolone, a synthetic glucocorticoid, could inhibit increase of phospholipase A2 activity in the lung and lead to protection against a model of acute respiratory distress syndrome in rabbits. Infusion of oleic acid (0.1 ml/kg/h, i.v. for 2 h) provoked pulmonary hemorrhage and edema, protein leakage and massive neutrophil infiltration, resulted in severe hypoxemia and impaired lung compliance, accompanying the increase of phospholipase A2 activity and interleukin-8, and degradation of surfactant in the bronchoalveolar lavage fluid. Infusion of methylprednisolone (60 mg/kg/h, i.v. for 30 min before the oleic acid and then 0.5 mg/kg/h, i.v. for 6 h) did not improve the above described lung injury induced by oleic acid, nor did it suppress phospholipase A2 activity and degradation of surfactant in bronchoalveolar lavage fluid, while it strongly reduced interleukin-8 levels in both plasma and bronchoalveolar lavage fluid. We conclude that methylprednisolone did not attenuate oleic acid-induced acute lung injury and this can be explained partly by its failure to reduce the increase of phospholipase A2 activity and the surfactant degradation in the lung, which might also account for its clinical ineffectiveness against early acute respiratory distress syndrome.

Original languageEnglish
Pages (from-to)209-216
Number of pages8
JournalEuropean Journal of Pharmacology
Volume433
Issue number2-3
DOIs
Publication statusPublished - Dec 21 2001
Externally publishedYes

Fingerprint

Acute Lung Injury
Phospholipases A2
Methylprednisolone
Oleic Acid
Surface-Active Agents
Adult Respiratory Distress Syndrome
Bronchoalveolar Lavage Fluid
Rabbits
Lung
Interleukin-8
Glucocorticoids
Lung Compliance
Neutrophil Infiltration
Lung Injury
Pulmonary Edema
Anti-Inflammatory Agents
Hemorrhage
Proteins

Keywords

  • Acute
  • Lung injury
  • Methylprednisolone
  • Oleic acid
  • Secretory phospholipase A
  • Surfactant

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Effect of methylprednisolone on phospholipase A2 activity and lung surfactant degradation in acute lung injury in rabbits. / Kuwabara, Kenji; Furue, Shingo; Tomita, Yasuhiko; Ueno, Masahiko; Ono, Takashi; Matsukawa, Akihiro; Yoshinaga, Masaru; Mikawa, Katsuya; Nishina, Kahoru; Shiga, Makoto; Obara, Hidefumi; Hori, Yozo.

In: European Journal of Pharmacology, Vol. 433, No. 2-3, 21.12.2001, p. 209-216.

Research output: Contribution to journalArticle

Kuwabara, K, Furue, S, Tomita, Y, Ueno, M, Ono, T, Matsukawa, A, Yoshinaga, M, Mikawa, K, Nishina, K, Shiga, M, Obara, H & Hori, Y 2001, 'Effect of methylprednisolone on phospholipase A2 activity and lung surfactant degradation in acute lung injury in rabbits', European Journal of Pharmacology, vol. 433, no. 2-3, pp. 209-216. https://doi.org/10.1016/S0014-2999(01)01507-2
Kuwabara, Kenji ; Furue, Shingo ; Tomita, Yasuhiko ; Ueno, Masahiko ; Ono, Takashi ; Matsukawa, Akihiro ; Yoshinaga, Masaru ; Mikawa, Katsuya ; Nishina, Kahoru ; Shiga, Makoto ; Obara, Hidefumi ; Hori, Yozo. / Effect of methylprednisolone on phospholipase A2 activity and lung surfactant degradation in acute lung injury in rabbits. In: European Journal of Pharmacology. 2001 ; Vol. 433, No. 2-3. pp. 209-216.
@article{54a9f8d229b649a9ab9486d65e90d140,
title = "Effect of methylprednisolone on phospholipase A2 activity and lung surfactant degradation in acute lung injury in rabbits",
abstract = "Glucocorticoids are the most potent and widely used anti-inflammatory agents, but they are not particularly effective against early phase of acute respiratory distress syndrome. We investigated whether methylprednisolone, a synthetic glucocorticoid, could inhibit increase of phospholipase A2 activity in the lung and lead to protection against a model of acute respiratory distress syndrome in rabbits. Infusion of oleic acid (0.1 ml/kg/h, i.v. for 2 h) provoked pulmonary hemorrhage and edema, protein leakage and massive neutrophil infiltration, resulted in severe hypoxemia and impaired lung compliance, accompanying the increase of phospholipase A2 activity and interleukin-8, and degradation of surfactant in the bronchoalveolar lavage fluid. Infusion of methylprednisolone (60 mg/kg/h, i.v. for 30 min before the oleic acid and then 0.5 mg/kg/h, i.v. for 6 h) did not improve the above described lung injury induced by oleic acid, nor did it suppress phospholipase A2 activity and degradation of surfactant in bronchoalveolar lavage fluid, while it strongly reduced interleukin-8 levels in both plasma and bronchoalveolar lavage fluid. We conclude that methylprednisolone did not attenuate oleic acid-induced acute lung injury and this can be explained partly by its failure to reduce the increase of phospholipase A2 activity and the surfactant degradation in the lung, which might also account for its clinical ineffectiveness against early acute respiratory distress syndrome.",
keywords = "Acute, Lung injury, Methylprednisolone, Oleic acid, Secretory phospholipase A, Surfactant",
author = "Kenji Kuwabara and Shingo Furue and Yasuhiko Tomita and Masahiko Ueno and Takashi Ono and Akihiro Matsukawa and Masaru Yoshinaga and Katsuya Mikawa and Kahoru Nishina and Makoto Shiga and Hidefumi Obara and Yozo Hori",
year = "2001",
month = "12",
day = "21",
doi = "10.1016/S0014-2999(01)01507-2",
language = "English",
volume = "433",
pages = "209--216",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Effect of methylprednisolone on phospholipase A2 activity and lung surfactant degradation in acute lung injury in rabbits

AU - Kuwabara, Kenji

AU - Furue, Shingo

AU - Tomita, Yasuhiko

AU - Ueno, Masahiko

AU - Ono, Takashi

AU - Matsukawa, Akihiro

AU - Yoshinaga, Masaru

AU - Mikawa, Katsuya

AU - Nishina, Kahoru

AU - Shiga, Makoto

AU - Obara, Hidefumi

AU - Hori, Yozo

PY - 2001/12/21

Y1 - 2001/12/21

N2 - Glucocorticoids are the most potent and widely used anti-inflammatory agents, but they are not particularly effective against early phase of acute respiratory distress syndrome. We investigated whether methylprednisolone, a synthetic glucocorticoid, could inhibit increase of phospholipase A2 activity in the lung and lead to protection against a model of acute respiratory distress syndrome in rabbits. Infusion of oleic acid (0.1 ml/kg/h, i.v. for 2 h) provoked pulmonary hemorrhage and edema, protein leakage and massive neutrophil infiltration, resulted in severe hypoxemia and impaired lung compliance, accompanying the increase of phospholipase A2 activity and interleukin-8, and degradation of surfactant in the bronchoalveolar lavage fluid. Infusion of methylprednisolone (60 mg/kg/h, i.v. for 30 min before the oleic acid and then 0.5 mg/kg/h, i.v. for 6 h) did not improve the above described lung injury induced by oleic acid, nor did it suppress phospholipase A2 activity and degradation of surfactant in bronchoalveolar lavage fluid, while it strongly reduced interleukin-8 levels in both plasma and bronchoalveolar lavage fluid. We conclude that methylprednisolone did not attenuate oleic acid-induced acute lung injury and this can be explained partly by its failure to reduce the increase of phospholipase A2 activity and the surfactant degradation in the lung, which might also account for its clinical ineffectiveness against early acute respiratory distress syndrome.

AB - Glucocorticoids are the most potent and widely used anti-inflammatory agents, but they are not particularly effective against early phase of acute respiratory distress syndrome. We investigated whether methylprednisolone, a synthetic glucocorticoid, could inhibit increase of phospholipase A2 activity in the lung and lead to protection against a model of acute respiratory distress syndrome in rabbits. Infusion of oleic acid (0.1 ml/kg/h, i.v. for 2 h) provoked pulmonary hemorrhage and edema, protein leakage and massive neutrophil infiltration, resulted in severe hypoxemia and impaired lung compliance, accompanying the increase of phospholipase A2 activity and interleukin-8, and degradation of surfactant in the bronchoalveolar lavage fluid. Infusion of methylprednisolone (60 mg/kg/h, i.v. for 30 min before the oleic acid and then 0.5 mg/kg/h, i.v. for 6 h) did not improve the above described lung injury induced by oleic acid, nor did it suppress phospholipase A2 activity and degradation of surfactant in bronchoalveolar lavage fluid, while it strongly reduced interleukin-8 levels in both plasma and bronchoalveolar lavage fluid. We conclude that methylprednisolone did not attenuate oleic acid-induced acute lung injury and this can be explained partly by its failure to reduce the increase of phospholipase A2 activity and the surfactant degradation in the lung, which might also account for its clinical ineffectiveness against early acute respiratory distress syndrome.

KW - Acute

KW - Lung injury

KW - Methylprednisolone

KW - Oleic acid

KW - Secretory phospholipase A

KW - Surfactant

UR - http://www.scopus.com/inward/record.url?scp=0035930835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035930835&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(01)01507-2

DO - 10.1016/S0014-2999(01)01507-2

M3 - Article

C2 - 11755154

AN - SCOPUS:0035930835

VL - 433

SP - 209

EP - 216

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -